At ECCO 2020, IBDoc® was again under the spotlight as 2 very interesting posters were presented. After 5 years of market presence, long term data about the impact of IBDoc® usage in clinical routine are beginning to emerge.
- info@buhlmannlabs.ch
- +41 61 487 12 12
Blog Archives
We would like to celebrate with you the World IBD Day on 19th May 2020 and raise awareness for more than 8.6 million people suffering from Inflammatory Bowel Disease (IBD).
We are pleased to inform you that the first External Quality Assessment (EQA) Scheme for Basophil Activation Test (BAT) is now available.
IBDoc®, a smartphone based application for fecal calprotectin testing at home, offers the perfect solution to keep patients out of clinics while still being able to monitor their disease.
Social Links